The U.S. National Science Foundation (NSF) announced that it has made offers and will award 2,500 Graduate Research Fellowships for the 2026-2027 academic year to outstanding graduate students across the United States who are pursuing research-based degrees in science, technology, engineering and mathematics (STEM).

(Funded by the U.S. National Science Foundation)
The U.S. National Science Foundation is investing up to $100 million to establish a nationwide network of open-access research facilities for quantum and nanoscale technologies, innovation, and workforce training. Through the new NSF National Quantum and Nanotechnology Infrastructure (NSF NQNI) program, NSF will support up to 16 sites over five years, providing students, researchers, and industry with access to state-of-the-art fabrication and characterization tools, instrumentation, and expertise. Together, the sites will form a shared national resource serving regional innovation ecosystems, including community colleges and small businesses.

(Funded by the U.S. National Science Foundation and the U.S. Department of Energy)
Researchers who discovered a versatile type of two-dimensional conductive nanomaterial, called a MXene, nearly a decade and a half ago, have now reported on a process for producing its one-dimensional cousin: the MXene nanoscroll. The group posits that these materials, which are 100 times thinner than human hair yet more conductive than their two-dimensional counterparts, could be used to improve the performance of energy storage devices, biosensors and wearable technology.

(Funded by the U.S. National Science Foundation and the National Institutes of Health)
Biomedical engineering researchers are exploring a novel treatment for alcohol-related liver disease using nanoparticles a thousand times smaller than a human hair. Despite this significant impact on society, alcohol-related liver disease (ARLD) remains largely unaddressed by medical research. A researcher aims to change that with a promising new therapy that she’s developing.

(Funded by the U.S. National Science Foundation and the U.S. Department of Energy)
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, like a fleet of trucks built from the same design. Researchers have characterized the shape and structure of LNPs in unprecedented detail, revealing that the particles come in a surprising variety of configurations. That variety isn’t just cosmetic: As the researchers found, a particle’s internal shape and structure correlates with how well it delivers therapeutic cargo to a particular destination.